XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps

المصدر: Nasdaq GlobeNewswire / 15 مارس 2024 14:34:50   America/Chicago